Prime Medicine, Inc. (PRME)
3.815
+0.14
(+3.95%)
USD |
NASDAQ |
Apr 17, 15:24
Prime Medicine EPS Diluted (Quarterly) : -0.2553 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | -2.389 |
| Lineage Cell Therapeutics, Inc. | 0.0035 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -46.08M |
| Revenue (Quarterly) | 0.838M |
| Total Expenses (Quarterly) | 46.92M |
| Enterprise Value | 601.37M |
| Gross Profit Margin (Quarterly) | -123.9% |
| Profit Margin (Quarterly) | -5.50K% |
| Earnings Yield | -36.02% |
| Normalized Earnings Yield | -36.02 |